Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health Chief Operating Officer Luke Whitworth reported two equity-related transactions in company common stock. He received a grant of 30,423 restricted stock units at no cost, which vest in three equal annual installments. Separately, 508 shares were disposed of to cover tax withholding obligations tied to equity compensation.
Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported mixed equity transactions. He received a grant of 12,678 shares of common stock at no cost as part of a restricted stock unit award. According to the footnote, one third of these units vest on each of the first three anniversaries of the grant date. Separately, 259 shares were disposed of at $35.24 per share to cover tax obligations associated with equity compensation, leaving him with 35,880 directly held shares after that tax-withholding transaction and 48,558 shares after the award grant.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two equity transactions. He acquired 9,579 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share. These units vest in three equal annual installments beginning on the first anniversary of the grant date.
He also disposed of 551 shares of common stock at $35.24 per share in a tax-withholding transaction used to satisfy obligations associated with equity compensation. After these transactions, his directly held common stock balance reported in the filing increased compared with prior holdings.
Option Care Health Chief Accounting Officer reports equity grant and tax share withholding. Nicole Maggio received 4,226 shares of common stock on February 18, 2026 as a grant or award at a stated price of $0 per share, bringing her direct holdings to 30,455 shares after that grant.
On February 17, 2026, 247 shares of common stock were disposed of at $35.24 per share to satisfy tax withholding obligations, leaving 26,229 directly owned shares after that tax-related transaction. The footnote explains that the restricted stock units from this award vest in three equal installments on each of the first, second, and third anniversaries of the grant date.
Option Care Health, Inc. reported that Chief Executive Officer John Charles Rademacher acquired 78,876 shares of common stock through a grant of restricted stock units. The award was at a stated price of $0.00 per share and increases his directly held position to 831,057 shares. These restricted stock units vest in three equal annual installments on the first, second, and third anniversaries of the grant date.
Adewunmi Femi reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. Chief Medical Officer Femi Adewunmi received a grant of 9,579 shares of common stock as an equity award. After this award, total directly held shares are 28,337. The restricted stock units vest in three equal annual installments on each of the first, second, and third anniversaries of the grant date.
Sethna Meenal reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. Chief Financial Officer Meenal Sethna reported an equity award of 27,045 shares of common stock, received as a grant with no cash price per share. These restricted stock units vest in three equal annual installments, and her directly held common stock increased to 82,112 shares after the award.
Option Care Health, Inc. reported that General Counsel and Corporate Secretary Collin Smyser acquired 15,213 shares of common stock through an equity award coded as a grant or other acquisition. The award consists of restricted stock units that vest in three equal installments on each of the first, second, and third anniversaries of the grant date.
After this grant, Smyser directly owns 94,215 shares of common stock. In addition, 2,500 shares are held indirectly through a revocable trust, reflecting separate indirect ownership.
Option Care Health, Inc. disclosed that its board of directors has increased the authorization for its 2025 share repurchase program from $500 million to $1 billion, with no specified expiration date. The company may buy back stock through open market purchases, privately negotiated transactions, block trades, or accelerated and other structured repurchase programs, with volume and timing determined by management based on market, regulatory, and corporate factors.
The company also furnished a press release with preliminary financial results for the three and twelve months ended December 31, 2025 and preliminary expectations for full year 2026, and an investor presentation tied to its appearance at the 44th Annual J.P. Morgan Healthcare Conference.
Option Care Health (OPCH) reported an insider purchase by a director. On November 3, 2025, the reporting person bought 38,000 shares of common stock at a weighted average price of $25.984 per share, executed across multiple trades priced between $25.835 and $26.235.
Following this transaction, the director beneficially owned 413,390 shares, held directly. The filing notes the weighted average and offers to provide detailed trade-by-trade pricing upon request.